ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,641Medicare Part D Prescriptions Filled, Including Refills

Rank: 410 out of 1499

$487K Total Retail Price of All Prescriptions

Rank: 352 out of 1499

454 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 5,470 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 488 349 1 3
HYDROCODONE-ACETAMINOPHEN 399 192 S3 2 4
LISINOPRIL 372 232 3 1
OMEPRAZOLE 244 165 4 5
CITALOPRAM HBR 243 165 5 14
METFORMIN HCL 236 126 6 8
AMLODIPINE BESYLATE 234 191 7 6
METOPROLOL TARTRATE 207 149 8 10
AMITRIPTYLINE HCL 150 70 R 9 49
LEVOTHYROXINE SODIUM 149 125 10 2
FUROSEMIDE 140 95 11 7
POTASSIUM CHLORIDE 126 95 12 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 77 13 25
HYDROCHLOROTHIAZIDE 116 89 14 9
WARFARIN SODIUM 111 50 15 12
RANITIDINE HCL 108 75 16 15
FLUTICASONE PROPIONATE 108 82 16 31
FLUOXETINE HCL 104 62 18 43
METOPROLOL SUCCINATE 91 61 19 20
TRAZODONE HCL 88 32 20 32
CLOPIDOGREL 79 59 21 39
ZOLPIDEM TARTRATE 75 27 22 23
RISPERIDONE 72 58 23 74
FENTANYL 70 0 S2 24 60
CYMBALTA 69 16 25 40
TRAMADOL HCL 66 35 26 16
ATORVASTATIN CALCIUM 65 35 27 17
TAMSULOSIN HCL 65 61 27 29
CARVEDILOL 63 50 29 22
PLAVIX 62 41 30 54
GLIMEPIRIDE 59 37 31 38
DILTIAZEM 24HR CD 57 45 32 82
ADVAIR DISKUS 57 42 32 37
VENLAFAXINE HCL ER 57 36 32 96
GABAPENTIN 57 21 32 13
OXCARBAZEPINE 56 53 36 298
DONEPEZIL HCL 55 55 37 35
PANTOPRAZOLE SODIUM 55 48 37 48
DIGOXIN 54 46 39 56
CEFUROXIME 53 34 40 163
OXYCODONE-ACETAMINOPHEN 52 21 S2 41 80
PREDNISONE 51 39 42 42
GLIPIZIDE ER 51 33 42 129
ESCITALOPRAM OXALATE 51 38 42 76
SINGULAIR 50 22 45 67
PRAVASTATIN SODIUM 50 31 45 18
ALLOPURINOL 50 50 45 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.